Abstract
Objectives To triage patients with a high likelihood of osteopenia before referring them for a standard bone mass density test for diagnosis.
Introduction Osteopenia defined by low bone mineral density, is a precursor for osteoporosis and is primarily associated with aging-linked natural bone loss in adulthood. The model and findings can be used to adopt an inclusive screening and swift treatment model that can work in most settings where resources are limited.
Methods We developed a diagnostic prediction rule based on clinical characteristics. A retrospective cohort of 798 patients who were going to be diagnosed with osteopenia or osteoporosis, within January-September 2022. The multivariable logistic regression to assess potential predictors. The logistic coefficients were transformed as a risk-based scoring system. The internally validation was performed using a bootstrapping procedure.
Results The model initially included seven predictors: sex, age, height, weight, body mass index, diabetes mellitus, and estimated glomerular filtration rate. However, after using backward elimination for model reduction, only three predictors—sex, age, and weight—were retained in the final model. The discrimination performance was assessed with the area under the receiver operating characteristic curve (AuROC); it was 0.779 (95%CI 0.74-0.82), and the calibration plot showed good calibration. For internal validation, bootstrap resampling was utilized, yielding an AuROC of 0.768 (95% CI 0.73-0.81), indicating robust performance of the model.
Conclusions This study developed and internally validated the Osteopenia Simple Scoring System. This clinical risk score could be one of the important tools for diagnosing osteopenia and allocating resources in resource-limited settings.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study protocol received approval from the Institutional Review Board of Suranaree University of Technology, with approval number COA No.32/2567.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Section on ethical consideration updated to clarify the date that accessed to patients data.
Data Availability
All relevant data are within the manuscript and its Supporting Information files.
